A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube

Thomas J. Herzog, Bradley J. Monk, Peter G. Rose, Patricia Braly, Jeffrey F. Hines, Maria C. Bell, Robert M. Wenham, Angeles Alvarez Secord, Lynda D. Roman, Mark H. Einstein, Richard D. Drake, Barrett H. Childs

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube'. Together they form a unique fingerprint.

Medicine & Life Sciences